• 文献检索
  • 文档翻译
  • 深度研究
  • 学术资讯
  • Suppr Zotero 插件Zotero 插件
  • 邀请有礼
  • 套餐&价格
  • 历史记录
应用&插件
Suppr Zotero 插件Zotero 插件浏览器插件Mac 客户端Windows 客户端微信小程序
定价
高级版会员购买积分包购买API积分包
服务
文献检索文档翻译深度研究API 文档MCP 服务
关于我们
关于 Suppr公司介绍联系我们用户协议隐私条款
关注我们

Suppr 超能文献

核心技术专利:CN118964589B侵权必究
粤ICP备2023148730 号-1Suppr @ 2026

文献检索

告别复杂PubMed语法,用中文像聊天一样搜索,搜遍4000万医学文献。AI智能推荐,让科研检索更轻松。

立即免费搜索

文件翻译

保留排版,准确专业,支持PDF/Word/PPT等文件格式,支持 12+语言互译。

免费翻译文档

深度研究

AI帮你快速写综述,25分钟生成高质量综述,智能提取关键信息,辅助科研写作。

立即免费体验

膀胱内脂质体疗法治疗间质性膀胱炎

Intravesical liposome therapy for interstitial cystitis.

作者信息

Tyagi Pradeep, Kashyap Mahendra, Majima Tsuyoshi, Kawamorita Naoki, Yoshizawa Tsuyoshi, Yoshimura Naoki

机构信息

Department of Urology, University of Pittsburgh, Pittsburgh, Pennsylvania, USA.

Department of Urology, Nagoya University Graduate School of Medicine, Nagoya, Aichi, Japan.

出版信息

Int J Urol. 2017 Apr;24(4):262-271. doi: 10.1111/iju.13317. Epub 2017 Mar 4.

DOI:10.1111/iju.13317
PMID:28258657
Abstract

Over the past two decades, there has been lot of interest in the use of liposomes as lipid-based biocompatible carriers for drugs administered by the intravesical route. The lipidic bilayer structure of liposomes facilitates their adherence to the apical membrane surface of luminal cells in the bladder, and their vesicular shape allows them to co-opt the endocytosis machinery for bladder uptake after instillation. Liposomes have been shown to enhance the penetration of both water-soluble and insoluble drugs, toxins, and oligonucleotides across the bladder epithelium. Empty liposomes composed entirely of the endogenous phospholipid, sphingomyelin, could counter mucosal inflammation and promote wound healing in patients suffering from interstitial cystitis. Recent clinical studies have tested multilamellar liposomes composed entirely of sphingomyelin as a novel intravesical therapy for interstitial cystitis. In addition, liposomes have been used as a delivery platform for the instillation of botulinum toxin in overactive bladder patients. The present review discusses the properties of liposomes that are important for their intrinsic therapeutic effect, summarizes the recently completed clinical studies with intravesical liposomes and covers the latest developments in this field.

摘要

在过去二十年中,人们对使用脂质体作为膀胱内给药的基于脂质的生物相容性载体产生了浓厚兴趣。脂质体的脂质双层结构有助于它们粘附在膀胱腔细胞的顶端膜表面,其囊泡形状使它们能够利用内吞机制在灌注后被膀胱摄取。脂质体已被证明可增强水溶性和非水溶性药物、毒素及寡核苷酸穿过膀胱上皮的渗透能力。完全由内源性磷脂鞘磷脂组成的空脂质体可以对抗黏膜炎症,并促进间质性膀胱炎患者的伤口愈合。最近的临床研究测试了完全由鞘磷脂组成的多层脂质体作为间质性膀胱炎的一种新型膀胱内治疗方法。此外,脂质体已被用作膀胱过度活动症患者注射肉毒杆菌毒素的递送平台。本综述讨论了对脂质体内在治疗效果重要的特性,总结了最近完成的膀胱内脂质体临床研究,并涵盖了该领域的最新进展。

相似文献

1
Intravesical liposome therapy for interstitial cystitis.膀胱内脂质体疗法治疗间质性膀胱炎
Int J Urol. 2017 Apr;24(4):262-271. doi: 10.1111/iju.13317. Epub 2017 Mar 4.
2
Effect of Intravesical Liposome-Based Nerve Growth Factor Antisense Therapy on Bladder Overactivity and Nociception in a Rat Model of Cystitis Induced by Hydrogen Peroxide.基于脂质体的神经生长因子反义疗法膀胱内给药对过氧化氢诱导的膀胱炎大鼠模型膀胱过度活动症和伤害感受的影响
Hum Gene Ther. 2017 Jul;28(7):598-609. doi: 10.1089/hum.2016.121. Epub 2017 Apr 18.
3
A Prospective, Multicenter, Double-Blind, Randomized Trial of Bladder Instillation of Liposome Formulation OnabotulinumtoxinA for Interstitial Cystitis/Bladder Pain Syndrome.一项前瞻性、多中心、双盲、随机临床试验,研究脂质体配方奥昔布宁毒素 A 膀胱灌注治疗间质性膀胱炎/膀胱疼痛综合征。
J Urol. 2017 Aug;198(2):376-382. doi: 10.1016/j.juro.2017.02.021. Epub 2017 Feb 12.
4
Advances in intravesical therapy for urinary tract disorders.用于治疗尿路疾病的膀胱内治疗进展。
Expert Opin Drug Deliv. 2016;13(1):71-84. doi: 10.1517/17425247.2016.1100166. Epub 2015 Oct 19.
5
Efficacy and Safety of Noninvasive Intravesical Instillation of Onabotulinum Toxin-A for Overactive Bladder and Interstitial Cystitis/Bladder Pain Syndrome: Systematic Review and Meta-analysis.非侵入性膀胱内注射A型肉毒杆菌毒素治疗膀胱过度活动症和间质性膀胱炎/膀胱疼痛综合征的疗效和安全性:系统评价和荟萃分析
Urology. 2019 Mar;125:50-57. doi: 10.1016/j.urology.2018.11.037. Epub 2018 Dec 12.
6
Intravesical liposome versus oral pentosan polysulfate for interstitial cystitis/painful bladder syndrome.膀胱内脂质体与口服聚硫酸戊聚糖治疗间质性膀胱炎/膀胱疼痛综合征的比较
J Urol. 2009 Oct;182(4):1393-400. doi: 10.1016/j.juro.2009.06.024. Epub 2009 Aug 15.
7
Novel Applications of Non-Invasive Intravesical Botulinum Toxin a Delivery in the Treatment of Functional Bladder Disorders.新型非侵入性膀胱内肉毒杆菌毒素 A 给药在治疗功能性膀胱障碍中的应用。
Toxins (Basel). 2021 May 18;13(5):359. doi: 10.3390/toxins13050359.
8
Potential Effect of Liposomes and Liposome-Encapsulated Botulinum Toxin and Tacrolimus in the Treatment of Bladder Dysfunction.脂质体以及脂质体包裹的肉毒杆菌毒素和他克莫司在治疗膀胱功能障碍中的潜在作用。
Toxins (Basel). 2016 Mar 18;8(3):81. doi: 10.3390/toxins8030081.
9
Intravesical treatment of bladder pain syndrome/interstitial cystitis: from the conventional regimens to the novel botulinum toxin injections.膀胱疼痛综合征/间质性膀胱炎的膀胱内治疗:从传统方案到新型肉毒毒素注射。
Expert Opin Investig Drugs. 2014 Jun;23(6):751-7. doi: 10.1517/13543784.2014.909406. Epub 2014 Apr 22.
10
Liposome-Encapsulated Botulinum Toxin A in Treatment of Functional Bladder Disorders.脂质体包裹肉毒毒素 A 治疗功能性膀胱障碍。
Toxins (Basel). 2022 Dec 1;14(12):838. doi: 10.3390/toxins14120838.

引用本文的文献

1
Promising Experimental Treatment in Animal Models and Human Studies of Interstitial Cystitis/Bladder Pain Syndrome.在间质性膀胱炎/膀胱疼痛综合征的动物模型和人体研究中具有前景的实验性治疗方法。
Int J Mol Sci. 2024 Jul 23;25(15):8015. doi: 10.3390/ijms25158015.
2
Enhancing Therapeutic Efficacy and Safety of Immune Checkpoint Inhibition for Bladder Cancer: A Comparative Analysis of Injectable vs. Intravesical Administration.提高膀胱癌免疫检查点抑制治疗的疗效和安全性:注射与膀胱内给药的比较分析。
Int J Mol Sci. 2024 May 1;25(9):4945. doi: 10.3390/ijms25094945.
3
Lower Urinary Tract Inflammation and Infection: Key Microbiological and Immunological Aspects.
下尿路炎症与感染:关键的微生物学和免疫学方面
J Clin Med. 2024 Jan 5;13(2):315. doi: 10.3390/jcm13020315.
4
Treating Lower Urinary Tract Symptoms in Older Adults: Intravesical Options.治疗老年人下尿路症状:膀胱内治疗选择。
Drugs Aging. 2023 Mar;40(3):241-261. doi: 10.1007/s40266-023-01009-5. Epub 2023 Mar 6.
5
The Efficacy and Safety of a Human Perirenal Adipose Tissue-Derived Stromal Vascular Fraction in an Interstitial Cystitis Rat Model.人肾周脂肪组织源性基质血管分数在间质性膀胱炎大鼠模型中的疗效和安全性。
Tissue Eng Regen Med. 2023 Apr;20(2):225-237. doi: 10.1007/s13770-022-00505-w. Epub 2023 Jan 4.
6
Effect of Ciprofloxacin-Loaded Niosomes on and Biofilm Formation.载环丙沙星脂质体对[具体内容缺失]和生物膜形成的影响。
Pharmaceutics. 2022 Nov 30;14(12):2662. doi: 10.3390/pharmaceutics14122662.
7
Applications of Nano/Micromotors for Treatment and Diagnosis in Biological Lumens.纳米/微米马达在生物腔道治疗与诊断中的应用。
Micromachines (Basel). 2022 Oct 19;13(10):1780. doi: 10.3390/mi13101780.
8
Nanotechnology as a tool to advance research and treatment of non-oncologic urogenital diseases.纳米技术作为推动非肿瘤性泌尿生殖系统疾病研究与治疗的工具。
Ther Adv Urol. 2022 Jul 26;14:17562872221109023. doi: 10.1177/17562872221109023. eCollection 2022 Jan-Dec.
9
Current Researches on Nanodrug Delivery Systems in Bladder Cancer Intravesical Chemotherapy.膀胱癌膀胱内化疗中纳米药物递送系统的当前研究
Front Oncol. 2022 May 24;12:879828. doi: 10.3389/fonc.2022.879828. eCollection 2022.
10
An update on treatment options for interstitial cystitis.间质性膀胱炎治疗选择的最新进展。
Prz Menopauzalny. 2020 Mar;19(1):35-43. doi: 10.5114/pm.2020.95334. Epub 2020 Apr 27.